Investment Institute
Macroeconomics

September Monthly Investment Strategy - The sum of all fears

KEY POINTS
Developments in the US economy continue to drive markets. The Fed started its easing cycle with an aggressive 50bp cut. US market volatility could persist into Novembers elections. Yet external factors are necessary to reconcile market pricing and US outlook.
China continues to concern. Domestic demand weakens further as house prices fall and the labour market softens. The authorities’ stimulus through industrial investment appears to be fading. We expect more stimulus, but the risks of a more severe slowdown in China are growing.
Adjustments to Japanese policy and impacts on repatriation flows have also impacted markets.
Eurozone activity is mixed but still subdued overall with pressing longer-term concerns, including the industrial complex, politics and fiscal stability.
These broader assessments are likely weighing on risk sentiment at the margins.

Related Materials

Full September 2024 Monthly Investment Strategy
Download September Macro Monthly (804.19 KB)
Investment Institute

Our experts and investment teams outline their key convictions.

Visit the Investment Institute
September Op-ed - Life after the Bang
Macroeconomics

September Op-ed - Life after the Bang

Investment Institute
July Op-Ed - Reconvergence
Macroeconomics Monthly Market Update

July Op-Ed - Reconvergence

Investment Institute
July Monthly Investment Strategy - One crazy summer
Macroeconomics Monthly Market Update

July Monthly Investment Strategy - One crazy summer

  • by David Page, Hugo Le Damany, and others
  • 24 July 2024 (10 min read)
Investment Institute

    Disclaimer

    This website is published by AXA Investment Managers Australia Ltd (ABN 47 107 346 841 AFSL 273320) (“AXA IM Australia”) and is intended only for professional investors, sophisticated investors and wholesale clients as defined in the Corporations Act 2001 (Cth).

    This publication is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments, nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

    Market commentary on the website has been prepared for general informational purposes by the authors, who are part of AXA Investment Managers. This market commentary reflects the views of the authors, and statements in it may differ from the views of others in AXA Investment Managers.

    Due to its simplification, this publication is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this publication is provided based on our state of knowledge at the time of creation of this publication. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    All investment involves risk , including the loss of capital. The value of investments and the income from them can fluctuate and investors may not get back the amount originally invested.